sign in · help · news · about ·

BibSonomy :: user :: kanefendt ::

tag user group author concept BibTeX key search:all search:kanefendt

The blue social bookmark and publication sharing system.

>
|
<

bookmarks

bookmarks per page: 5 10 20 50 100

RSS BibTeX RDF more

publications

(17)

<< < 1 > >>

Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II
P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, and E. Rozet J.Pharm.Biomed.Anal. 45(1):70-81 (2007)
to Analytical Calibration Chemistry Clinical France Laboratories Laboratory Medical Pharmaceutical Reference Reproducibility Research Results Societies Standards Techniques methods of standards by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III
P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Laurentie, N. Mercier, G. Muzard, L. Valat, and E. Rozet J.Pharm.Biomed.Anal. 45(1):82-96 (2007)
to & Analytical Calibration Chemistry Clinical France Laboratories Laboratory Medical Pharmaceutical Reference Reproducibility Research Results Societies Standards Techniques data methods numerical of standards statistics by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
The clinical toxicity profile of vascular endothelial growth factor VEGF and vascular endothelial growth factor receptor VEGFR targeting angiogenesis inhibitors; a review
F. A. Eskens, and J. Verweij Eur.J.Cancer 42(18):3127-3139 (2006)
to & A Angiogenesis Antibodies Endothelial Factor Growth Humans Inhibitors Kinase Kinases Medical Monoclonal Neoplasms Neovascularization Oncology Pathologic Protein Protein-Tyrosine Receptors Tyrosine Vascular adverse antagonists blood control drug effects inhibitors prevention protein supply therapy toxicity by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan
B. Vincenzi, D. Santini, A. Russo, M. Gavasci, F. Battistoni, G. Dicuonzo, L. Rocci, V. M. Rosaria, N. Gebbia, and G. Tonini Pharmacogenomics. 8(4):319-327 (2007)
to & A Adult Aged Antibodies Antineoplastic Biological Camptothecin Chemotherapy Colorectal Combined Disease Endothelial Factor Female Growth Humans Male Markers Medical Middle Monoclonal Neoplasms Oncology Outcome Progression Prospective Protocols Rate Studies Survival Treatment Tumor Vascular administration analogs antagonists blood derivatives dosage drug inhibitors methods mortality response therapeutic therapy trends use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivity
E. Carcereny, and J. Maurel Rev.Recent Clin.Trials 1(2):113-118 (2006)
to & Animals Antibodies Biomarkers Carcinoma Colorectal Drug Epidermal Europe Factor Factors Growth Humans Immunologic Ligands Medical Monoclonal Mutation Neoplasm Neoplasms Oncology Pharmacological Phosphorylation Prognosis Receptor Resistance Tyrosine antagonists genetics inhibitors pharmacology response therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N. Murukesh, C. Dive, and G. C. Jayson Br.J.Cancer (2009)
to Blood Growth Health Medical Oncology Plasma Pressure Prospective Research Studies blood identify response by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Validation of analytic methods for biomarkers used in drug development
C. H. Chau, O. Rixe, H. McLeod, and W. D. Figg Clin.Cancer Res. 14(19):5967-5976 (2008)
to Agents Animals Antineoplastic Biological Biomarkers Chemistry Design Drug Evaluation Genome Genomics Human Humans Markers Medical Mice Neoplasms Oncology Outcome Pharmaceutical Pharmacological Preclinical Research Treatment Tumor analysis drug metabolism methods pharmacology therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors
F. A. Eskens, N. Steeghs, J. Verweij, J. L. Bloem, O. Christensen, Doorn L. van, J. Ouwerkerk, M. J. Jonge, J. W. Nortier, J. Kraetzschmar, P. Rajagopalan, and H. Gelderblom J.Clin.Oncol. 27(25):4169-4176 (2009)
to & A Administration Adolescent Adult Aged Angiogenesis Biological Contrast Dose Dose-Response Drug Endothelial Factor Factors Fatigue Female Growth Human Humans Hypertension Imaging Inhibitors Kinase Magnetic Male Markers Maximum Media Medical Metastasis Middle Neoplasm Neoplasms Oncology Oral Outcome Pharmacokinetics Plasma Platelet-Derived Protein Proteins Proto-Oncogene Pyridazines Pyridines Receptor Receptor-2 Receptor-3 Relationship Research Resonance Safety Schedule Time Tolerated Treatment Tumor Tyrosine Vascular Young administration adverse antagonists beta blood c-kit diagnostic dosage drug effects enzymology inhibitors methods pathology protein response supply therapy toxicity use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Tumoural expression and circulating level of VEGFR-3 Flt-4 in metastatic melanoma patients: correlation with clinical parameters and outcome
R. Mouawad, J. P. Spano, E. Comperat, F. Capron, and D. Khayat Eur.J.Cancer 45(8):1407-1414 (2009)
to Assay C Endothelial Enzyme-Linked Factor France Growth Immunosorbent Laboratories Medical Oncology Prognosis Research Vascular cells by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
L. F. Kontovinis, K. T. Papazisis, P. Touplikioti, C. Andreadis, D. Mouratidou, and A. H. Kortsaris BMC.Cancer (2009)
to Carcinoma Gastrointestinal Medical Oncology Plasma Population Stromal Tumors Tyrosine analysis methods protein response by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway
J. M. Roodhart, M. H. Langenberg, E. Witteveen, and E. E. Voest Curr.Clin.Pharmacol. 3(2):132-143 (2008)
to & A Agents Angiogenesis Animals Antibodies Antineoplastic Blood Coagulation Diseases Disorders Endothelial Factor Growth Humans Hypertension Hypothyroidism Inhibitors Intestinal Medical Nervous Oncology Perforation Proteinuria Receptors Signal System Transduction Tyrosine Vascular adverse antagonists chemically drug effects induced inhibitors pathology therapeutic therapy toxicity use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase I dose escalation study of telatinib BAY 57-9352 in patients with advanced solid tumours
D. Strumberg, B. Schultheis, I. A. Adamietz, O. Christensen, M. Buechert, J. Kraetzschmar, P. Rajagopalan, M. Ludwig, A. Frost, S. Steinbild, M. E. Scheulen, and K. Mross Br.J.Cancer 99(10):1579-1585 (2008)
to & 80 Adult Aged Agents Angiogenesis Antineoplastic Carcinoma Dose Female Growth Humans Hypertension Imaging Inhibitors Magnetic Male Maximum Medical Middle Neoplasms Oncology Plasma Pyridazines Pyridines RANGE Resonance Tolerated Tyrosine administration and blood dosage drug over response therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Anti-VEGF therapy: the search for clinical biomarkers
R. Longo, and G. Gasparini Expert.Rev.Mol.Diagn. 8(3):301-314 (2008)
to & A Agents Angiogenesis Animals Antibodies Antineoplastic Biological Cells Diagnostic Endothelial Factor Growth Human Humans Imaging Inhibitors Markers Medical Monoclonal Neoplasms Oncology Piperazines Prognosis Pyrimidines Tumor Vascular antagonists cells diagnosis drug identify inhibitors metabolism methods pathology protein response therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Platelet: transporter of vascular endothelial growth factor
H. M. Verheul, K. Hoekman, Bakker S. Luykx de, C. A. Eekman, C. C. Folman, H. J. Broxterman, and H. M. Pinedo Clin.Cancer Res. 3(12 Pt 1):2187-2190 (1997)
to & A Activation Antineoplastic Blood Breast Burden Chemotherapy Colony-Stimulating Combined Cyclophosphamide Doxorubicin Endothelial Factor Factors Female Granulocyte-Macrophage Growth Healing Humans Lymphokines Medical Neoplasms Oncology Platelet Platelets Protocols Reference Research Tumor Values Vascular Wound administration adverse blood dosage drug effects physiology therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer
L. C. Snyder, I. Astsaturov, and L. M. Weiner Clin.Colorectal Cancer (2005)
to & Administration Amplification Antibodies Approval Binding Colorectal Drug Epidermal Exanthema Factor Food Gene Growth Humans IgG Ligands Medical Molecular Monoclonal Neoplasms Oncology Phosphorylation Prognosis Receptor Receptors Signal Sites States Transduction Tyrosine United Weight and antagonists biosynthesis cells chemically drug induced inhibitors pharmacology physiology physiopathology response therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I
P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, and L. Valat J.Pharm.Biomed.Anal. 36(3):579-586 (2004)
to Analytical Chemistry Clinical France Laboratory Medical Pharmaceutical Reproducibility Results Societies Techniques diagnosis methods of standards by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Antiangiogenic therapy for cancer: current and emerging concepts
R. K. Jain Oncology Williston.Park 19(4 Suppl 3):7-16 (2005)
to & A Angiogenesis Antibodies Antineoplastic Chemotherapy Combined Delivery Drug Endothelial Factor Growth Humans Inhibitors Laboratories Medical Monoclonal Neoplasms Neovascularization Oncology Oxygen Pathologic Protocols Signal Systems Transduction Vascular antagonists blood drug inhibitors pathology pharmacology supply therapeutic therapy trends use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)

<< < 1 > >>publications per page: 5 10 20 50 100

a gripper